The present study enumerates the effectiveness of ethanolic leaf extract of A. indica against circulating microfilariae (mf) of D. immitis in vivo of Canis familiaris. An ethanolic extract was prepared from the leaves of A. indica (EEA) and treated on dogs infected with the filarial nematode Dirofilaria immitis, the causative agent of canine cardiopulmonary dirofilariasis.
Introduction
Cardiopulmonary dirofilariasis or heartworm disease of dogs and other canids is caused by the filarial nematode Dirofilaria immitis (D. immitis, family Onchocercidae) and widely distributed in the subcontinents of Africa, Australia, Asia and Europe (Genchi et al., 2005) . The causative parasite naturally resides in the pulmonary arteries, occasionally inside the right heart and sometimes the aberrant movement of them to various other parts of the body of affected animals can be noted (Bowman et al., 2009) . Diversified clinical symptoms due to D. immitis infection in dogs associated with different stages of infection that can ultimately lead to the death of the affected animals (Bowman et al., 2009 , Nelson et al., 2014 . Adult females upon copulation release thousands of microfilariae (mf) into the circulation and make it prone for the transmission through mosquitoes. Infection to naive canids occurs when infective (3 rd stage that developed from mf after two molting inside the vector) larvae of D. immitis enter into the circulation via a vector (Bowman et al., 2009) . Treatment against heartworm disease is troublesome, as melarsomine dihydrochloride, the only approved macro-filaricidal by the US FDA having some complications in infected dogs as the dead worms decompose into small fragments which can cause blockage of the pulmonary arterioles and capillary beds that can lower the blood flow significantly and carries risk of probable lethality with some adverse neurological reactions (Godel et al., 2012) . Macrocyclic lactones (ivermectin, milbemycin oxime, selamectin, moxidectin) are in use for more than 25 years as microfilaricides that mainly block transmission (Godel et al., 2012 , Bourguinat et al., 2011 . However, resistance of D.
immitis against these choices of drugs is definitely a possibility and a matter of discussion and it was found that almost 1/5 th of the dogs that received periodic heartworm preventive medicine of the macrocyclic lactone groups without any adulticidal agents can be continued to have circulating microfilariae that possibly can evolve into resistance strain (Bowman and Mannella, 2011) . Thus, alternative therapeutics is essentially needed. In this regard, some plant extracts or isolated phytocompounds have shown potentials to become new alternative chemotherapeutics against heartworm disease. In our previous research it was found that ethanolic extract from the funicles of Acacia auriculiformis and from the leaves of Azadirachta indica was found to be effective against D. immitis, in vivo and in vitro, respectively (Chakraborty et al., 1995 , Mukherjee et al., 2014 . Previously, we have demonstrated the antifilarial activity of an ethanolic extract from the leaves of A. indica (EEA) on D. immitis in vitro through alteration of redox parameters and subsequent apoptosis induction (Mukherjee et al., 2014) . Here, we extended our previous study by examining the effectiveness of EEA against circulating D.
immitis mf in vivo using the natural host of the parasite i.e. Canis familiaris.
Materials and Methods
The protocol of this study was approved by the Institutional Animal Ethical Committee, Visva-Bharati University, Santiniketan-731 235, India. Animal sampling was performed under the surveillance and guidance of trained officials and resource persons from Bolpur Subdivisional Veterinary Hospital, Department of Animal Resource Development, Govt. of West Bengal, India. Adult dogs of both male and female were included in the study apart from the injured, lactating or pregnant ones. Ethanolic extract of the leaves of A. indica was prepared and characterized for chemo-profiling according to Mukherjee et al (2014) . Various doses (25 and 50 mg/kg b. wt. / twice a day) of EEA were selected for treating the infected dogs orally and were prepared in empty capsules. Before treatment, D. immitis infected adult street-dogs (C. familiaris) were screened by random sampling of blood withdrawn from the recurrent tarsal vein of the hind legs with the aid of sterile Vacutainer equipment (4ml, plastic whole blood tube with Spray-coated K2EDTA; BD, USA) in their natural territorial zones (all the sampling were done at 9 A.M. ± 15 min IST). Circulating mf were detected by visualizing the Giemsa stained blood slide under the microscope following our previous report (Mukherjee et al., 2014) . For in vivo studies, the infected dogs were randomized into control and experimental groups and distributed into 3 groups of animals (n= 6) as shown in Table 1 . For each group prior to in vivo trial, continuous blood sampling was performed at weekly intervals for 12 weeks to observe any natural change over time (Table 2) . Group II and Group III, received EEA at 25 and 50 mg/kg b.wt./twice a day, respectively. Group I, served as control (matching placebo for 15 days). EEA was given for 15 days continuously in empty capsules filled with it and embedded in a piece of bread at 12 h interval. To observe the changes in the circulating D. immitis mf count due to EEA administration continuous sampling was carried out for 30 days with a weekly interval thereafter at 15 days interval up to day 90. Additional sampling was performed thereafter with a monthly interval of up to 6 months. Evaluation of toxicity due to EEA exposure was performed following the guidelines from the Organization for Economic Cooperation and Development (OECD) (OECD, 2009) . Biochemical tests included measurement of serum total protein, albumin, globulin, total bilirubin both conjugated and un-conjugated, serum glutamate oxaloacetic transaminase (SGOT), serum glutamate pyruvic transaminase (SGPT) and alkaline phosphatase following the standard laboratory methods at different time points during treatment and posttreatment, i.e., day 0, 15, 30 and 180. Data were collected in triplicates, subjected to Student's ttest after accessing normality distribution through Shapiro-Wilk test of normality by SPSS software and finally expressed as mean ± SEM. Significant differences, p-value <0.05 (*), <0.001(**) between the means of each sample group on the day '0' count and experiment day count were analyzed by using MS Excel.
Results and Discussion
The traditional rather ethno-medication system still has the potential to serve in the modern medicinal practice especially at drug developmental research as apart from their direct effectiveness against different ailments, natural products can even provide a storehouse of 6 various active compounds. Primary evaluation of the efficacy of EEA against D. immitis in vitro showed that EEA caused its effectiveness by altering the redox parameters and subsequent induction of apoptosis in D. immitis mf (Mukherjee et al., 2014) and therefore EEA have possibilities of controlling mf densities in infected animals and act as a transmission regulator.
Random microscopic examinations for D. immitis mf infections of dogs revealed that infections were at different densities and thus grouped into three with six animals in each group having comparable infections and did not vary significantly during pretreatment period (Table 2; Fig. 1-A) . Treatment results were provided in Table 2 and Fig. 1-B and Fig. 1 -C. Day 0 count is the mean of all the pretreatment observations. Oral administrations of EEA at 25 and 50 mg/kg b.wt./twice a day for 15 days revealed that EEA was effective in reducing circulating mf count significantly and that too was dose-dependent. For Group II (25 mg/kg b.wt./twice a day for 15 days) EEA treatment resulted in a reduction in mf density and the maximum reduction of mf count (77.9%) was recorded on day 60 relative to pre-treatment count. Thereafter mf density increased with a minor change and maintained reduction of 49.5% on day 180. Whereas for group III (50 mg/kg b.wt./twice a day for 15 days), mf count was reduced drastically to 86.7% on day 60 but like that of the group II got increased thereafter and finally maintained 64.1% reduction on day 180. Significant (p< 0.05) reduction of circulating mf as well as percentage reduction were clearly dose-dependent and followed a particular trend, reached maximum reduction on day 60 and then got increased but the increment of mf count post-treatment was much slower than initial reduction in circulating mf count after EEA administration (Fig. 1-B and Fig. 1-C) . The effect of EEA on circulating mf did not show a drastic fall in mf count suddenly, but the effect was continuous and persistent. The continuous depletion is more useful as a sudden mass death of mf can cause severe lethal complications due to the sudden heavy release of mf antigens (Merawin et al., 2010) . To check if EEA has any effect on adults, from each blood sample, serum was also collected and examined for adult D. immitis Ag (Antigen Rapid Canine Heartworm Ag Test Kit 2.0" BioNote, Inc. Korea). It was found that EEA did not produce any considerable change in circulating adult Ag repertoire and possibly EEA produced little or no effect on adult parasites (Fig. 1-D) . Preventive action of EEA executed through altruistic prevention as reduction of the circulatory mf was highly evident but the persistence of the adult worms in the dogs. It was noticed that EEA may not have any profound effect on the adults of D. immitis, as noticed by the antigen detection tests but reduction in circulating mf can have an effect on transmission blockage which is in continuation of our earlier report where EEA mediated apoptotic death of the exposed D. immitis mf in vitro (Mukherjee et al., 2014) .
Although it is very early to emphasize this part of the conclusion as the remaining number of mf is quite enough to continue the transmission but opens provision of further research and finding out the most important compound from EEA that is actually causing the reduction and maybe in future can confirm a therapeutic lead as an complete circulatory D. immitis macrofilaricidal agent. Furthermore, EEA administration did not alter any of the physico-biochemical parameters significantly alongside the improvement of liver function in the treated dogs by means of sustained reduction of serum bilirubin level, alkaline phosphatase, SGOT and SGPT were also noticed ( Table 3) .
Conclusion
Transmission of D. immitis mf does majorly reliant on their sufficient presence in the host circulation as well as on the number of infected hosts where vector availability is not of any question. Therefore, the use of EEA suppresses mf count in the infected population and additionally improves the overall health status of treated dogs which can be helpful to combat the disease. With additional research and exploration of the main effective compound of the extract liable for circulating microfilaria reduction can emerge as an alternative mean during unavailability of the common microfilaricides and during the occurrence of resistance.
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